Dikmen S S, Temkin N R, Miller B, Machamer J, Winn H R
Department of Rehabilitation Medicine, University of Washington, Seattle 98195.
JAMA. 1991 Mar 13;265(10):1271-7.
In order to determine potential negative neurobehavioral effects of phenytoin given to prevent the development of posttraumatic seizures, 244 subjects were randomized to phenytoin or placebo. They received neurobehavioral assessments at 1 and 12 months postinjury while receiving their assigned drug and at 24 months while receiving no drugs. In the severely injured, phenytoin significantly impaired performance at 1 month. No significant differences were found as a function of phenytoin in the moderately injured patients at 1 month or in either severity group at 1 year. Patients who stopped receiving phenytoin according to protocol between 1 and 2 years improved more than corresponding placebo cases on several measures. We conclude that phenytoin has negative cognitive effects. This, combined with lack of evidence for its effectiveness in preventing posttraumatic seizures beyond the first week, raises questions regarding its use for long-term prophylaxis. Our findings do not negate phenytoin's proven efficacy in controlling established seizures nor do they indicate that its cognitive effects are worse than other anticonvulsant drugs.
为了确定给予苯妥英钠预防创伤后癫痫发作的潜在负面神经行为影响,244名受试者被随机分为苯妥英钠组或安慰剂组。他们在受伤后1个月和12个月接受指定药物治疗时以及在24个月不接受药物治疗时接受神经行为评估。在重伤患者中,苯妥英钠在1个月时显著损害了其表现。在中度受伤患者中,1个月时未发现苯妥英钠对其有显著差异,在1年时,两个严重程度组均未发现显著差异。在1至2年期间按照方案停止接受苯妥英钠治疗的患者在多项指标上比相应的安慰剂组患者改善得更多。我们得出结论,苯妥英钠具有负面认知影响。这一点,再加上缺乏证据表明其在预防创伤后癫痫发作超过第一周方面的有效性,引发了关于其长期预防用途的问题。我们的研究结果并未否定苯妥英钠在控制已确诊癫痫发作方面已被证实的疗效,也未表明其认知影响比其他抗惊厥药物更严重。